At Oxford BioSystems we’ve observed that biomedical research increasingly relies on analysing multiple biomarkers at once. Whether studying immune responses, nutritional status, or complex disease pathways, running multiple single-analyte ELISAs can quickly become costly, time-consuming and sample-intensive. 

In this article, we explore how multiplex ELISA technology provides a more efficient alternative, highlight key applications, and outline the Q-View™ Imager LS Loan Programme, which enables researchers to evaluate multiplex ELISA assays in their own lab.

 

What is a Multiplex ELISA and why are researchers adopting it?

Multiplex ELISAs allow multiple analytes to be measured simultaneously in a single well of a standard 96-well plate. Compared with traditional ELISA workflows, this offers several key advantages:

• Higher data output per sample: Researchers can generate a full biomarker panel from a single assay.
• Reduced sample volume requirements: Ideal for clinical studies or precious sample sets.
• Improved efficiency and cost control: Fewer plates, reagents and ELISA runs.
• Streamlined experimental workflows: Less hands-on time while producing more comprehensive datasets.

As research increasingly focuses on biological networks rather than individual markers, multiplex assays are becoming an important tool for many laboratories.

 

Multiplex ELISA technology from Quansys Biosciences

Multiplex ELISA technology from Quansys Biosciences is enabling researchers to generate high-quality biomarker data more efficiently. Their Q-Plex™ arrays are multiplex ELISAs containing specific capture antibodies printed as distinct, individual spots in each well of a 96-well microtiter plate, allowing multiple analytes to be measured simultaneously from a single sample. 

Quansys offer a wide range of standard kits, utilising human, mouse and other biomarkers. The assays are also highly customisable. Scientists can select from over 160 cytokines, chemokines and other biomarkers, as listed on the Quansys website. This combination of efficiency, flexibility and scalability makes Q-Plex™ assays ideal for applications ranging from immunology and vaccine studies to nutrition and global health research. If you can’t find what you are looking for, please contact us to discuss your specific requirements. 

At Oxford BioSystems, we are currently supporting UK and Irish laboratories exploring multiplex assays with a limited Q-View™ Imager LS loan programme. Further details are provided at the end of this article.

 

How Multiplex ELISA Kits are used by researchers

Multiplex ELISA technology supports a wide range of applications across biomedical and global health research. Below are just three examples of how researchers are currently using multiplex assays in practice. These examples highlight the versatility of Q-Plex™ panels, but the technology can be applied in many other research contexts as well.

1. Cytokine and Chemokine Profiling in Immunology and Infection Research

Cytokines and chemokines play central roles in immune signalling, inflammation and host responses to infection. Understanding immune dynamics requires analysing multiple biomarkers simultaneously rather than individually.
Multiplex cytokine and chemokine panels allow researchers to:

• Characterise immune responses in infectious disease studies
• Evaluate vaccine efficacy and immunogenicity
• Investigate inflammatory pathways
• Study immune modulation in translational research

By measuring multiple signalling molecules in a single assay, researchers gain a more comprehensive view of immune activity while conserving valuable samples and reducing assay time.

2. Micronutrient analysis in global health and nutrition studies

Multiplex assays are widely used to study micronutrient deficiencies and their impact on disease outcomes, child development and public health. Researchers, including universities and other groups collaborating with partners in regions such as Africa and the Middle East, use the Q-Plex™ Human Micronutrient v2 (7-Plex) to measure multiple nutritional biomarkers simultaneously, making it ideal for large cohort studies.

This panel also complements the Q-Plex™ Human Environmental Enteric Dysfunction (11-Plex), enabling a more holistic view of nutrition-related disease mechanisms while improving efficiency and conserving precious sample material.

3. Pneumococcal vaccine research

Multiplex ELISAs are also well suited to vaccine and infectious disease research, including pneumococcal studies. 

Antibodies play an essential role in protection against pneumococcal disease, with human serum antibodies typically targeting the polysaccharide capsule in a serotype-specific manner. There are multiple vaccination options available for protection against Streptococcus pneumoniae, with the major difference being the number and composition of specific serotypes included in the vaccine. 

Multiplex ELISAs enable simultaneous measurement of antibody responses to multiple serotypes within a single assay, supporting efficient evaluation of vaccine responses and immunogenicity.

Quansys offer 9-Plex and 14-Plex assays to detect antibodies recognising serotypes commonly used in vaccination targets.

 

Why many laboratories are transitioning to Multiplex ELISA

• As research projects scale and questions become more complex, the ability to generate rich, multi-parameter datasets efficiently is becoming increasingly important. Multiplex ELISA platforms such as Q-Plex™ provide:
• Efficient biomarker panel analysis
• Reduced assay time and costs
• Improved use of limited samples
• Greater experimental scalability

For many laboratories, evaluating the technology through an instrument loan is the most practical first step.

 

Evaluate Multiplex ELISAs in your own lab: Q-View™ Imager LS Loan Programme

Adopting a new assay platform can require both time and investment. To help researchers assess multiplex ELISA workflows before purchasing instrumentation, we have a limited number of Q-View™ Imager LS instruments available for short-term loan.

The Q-View™ Imager LS captures and analyses chemiluminescent signals from Q-Plex™ ELISA plates, enabling accurate quantification across entire biomarker panels. For many research groups, this will provide a practical way to:

• Test multiplex ELISA technology with real samples
• Evaluate panel-based biomarker analysis in their own workflow
• Generate multi-analyte datasets more efficiently
• Reduce upfront risk when introducing multiplex assays
• Assess throughput advantages over traditional ELISAs

Importantly, Q-Plex™ assays cover a wide range of research areas, including immune signalling, inflammation, nutrition, infectious disease, angiogenesis and more - making the loan programme relevant to many different fields. Availability is limited, so we recommend registering interest early.

For laboratories requiring increased sensitivity or higher throughput, the Q-View™ Imager Plus is also available. For more information click here.

 

Register Interest: Limited Q-View™ Imager LS Loans Available >